Skip to content

Medpace Holdings, Inc. MEDP Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin21%-0.1pp21.1%0.0pp21.5%+1.8pp21.4%+2.6pp21.2%+3.1pp
Net margin17.2%-2.1pp17.8%-1.3pp18.4%+0.7pp18.7%+2.0pp19.3%+3.4pp
EBITDA margin22.1%-0.4pp22.3%-0.3pp22.7%+1.6pp22.7%+2.5pp22.5%+3.0pp
Free cash flow margin26.5%+1.5pp26.9%-0.2pp28.7%+2.8pp26%+1.2pp25.1%+1.0pp
Returns
Return on equity77.3%+11.4pp70.2%+11.8pp73.7%+19.6pp89.4%+30.5pp65.8%+4.5pp
Return on assets22.9%+0.3pp22.1%+0.6pp22.6%+2.1pp24%+3.5pp22.5%+3.0pp
Return on invested capital229.9%+121pp220%+123pp159.9%+84.4pp118.2%+51.1pp108.9%+47.7pp
Efficiency
Asset turnover1.3×+0.2×1.2×+0.1×1.2×+0.1×1.3×+0.1×1.2×-0.1×
Liquidity
Current ratio0.8×+0.1×0.7×-0.2×0.6×-0.4×0.4×-0.5×0.7×0.0×
Quick ratio0.8×+0.1×0.7×-0.2×0.6×-0.4×0.4×-0.5×0.7×0.0×
Cash ratio0.5×+0.1×0.4×-0.2×0.2×-0.4×-0.5×0.4×0.0×
Leverage
Debt-to-equity0.2×0.0×0.3×+0.1×0.5×+0.3×0.9×+0.7×0.3×0.0×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA-0.9×-0.3×-0.6×+0.5×-0.3×+0.9×0.2×+1.1×-0.6×+0.1×
Interest coverage49.2×+32.5×41.9×+24.0×29.9×20.8×16.7×
Per Share
Book value per share$20.66+8.6%$15.55-39.7%$10.19-62.9%$5.91-75.1%$19.03-9.3%
Valuation
Market capitalization$13.63B+46.8%$15.82B+53.2%$14.44B+39.6%$9.06B-28.7%$9.28B-25.5%
Enterprise value$13.12B+45.9%$15.46B+57.7%$14.3B+45.4%$9.17B-25.8%$8.99B-26.4%
Price / earnings29.6×+7.3×35.1×+9.5×33.4×+5.1×21.7×-15.7×22.3×-17.6×
Price / sales5.1×+0.8×6.3×+1.4×6.1×+1.1×4.1×-2.2×4.3×-2.0×
Price / book22.8×+7.1×34.5×+22.0×49.2×+37.5×52.6×+35.9×15.6×-2.9×
EV / EBITDA22.2×+3.7×27.5×+6.9×26.7×+4.2×18.1×-12.1×18.5×-13.5×
EV / sales4.9×+0.7×6.1×+1.5×6.1×+1.3×4.1×-2.0×4.2×-2.1×
Free cash flow yield5.2%-0.6pp4.3%-1.2pp4.7%-0.5pp6.4%+2.4pp5.8%+2.0pp
Earnings yield3.4%-1.1pp2.9%-1.1pp3%-0.5pp4.6%+1.9pp4.5%+2.0pp
PEG ratio2.8×+2.1×+2.4×1.8×+1.0×0.9×-0.5×0.7×-1.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Medpace Holdings, Inc.'s ratios come from?
Every ratio is computed from Medpace Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.